Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 86.74
-1.66 (-1.88%)
Aug 6, 2025, 3:00 PM CST
Accolade Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 35.29 billion as of August 6, 2025. Its market cap has increased by 64.44% in one year.
Market Cap
35.29B
Enterprise Value
34.49B
Revenue
2.95B
Ranking
n/a
PE Ratio
40.20
Stock Price
$86.74
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 35.29B, an increase of 145.72%. That is a compound annual growth rate of 17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 35.29B | 18.22% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 413.99B |
| Shenzhen Mindray Bio-Medical Electronics | 274.89B |
| WuXi AppTec | 261.30B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.88B |
| Aier Eye Hospital Group | 119.73B |
| Sichuan Biokin Pharmaceutical | 116.85B |
| Shanghai United Imaging Healthcare | 107.66B |
| Yunnan Baiyao Group Co.,Ltd | 100.11B |